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Fanconi anemia (FA) is an autosomal recessive chromosomal instability syndrome characterized by congenital abnormalities, progressive bone marrow failure, and 
cancer predisposition [1,2]. In 1927, Guido Fanconi first reported 
3 brothers with pancytopenia and physical abnormalities. The 
current diagnostic test for FA consists of cytogenetic quantitation 
of chromosomal breakage in response to diepoxybutane (DEB) or 
mitomycin C (MMC). FA cells are sensitive to DNA cross-linking 
agents. Complementation analysis of FA cells using somatic cell 
fusion has facilitated the identification of thirteen complementation 
groups so far, suggesting that FA is a genetically heterogeneous 
disorder and sequentially named as  FANC (subtypes A, B, C, D1, 
D2, E, F, G, I, J, L, M, N) [1-3]. The majority of affected children 
belong to FA Group A [1,2].
The male-to-female ratio in the literature cases is 1.2:1, 
although equal numbers are expected in autosomal recessive 
disease. FA has been diagnosed from birth to age 48 years, with 
a median age of 7-8 years. Individuals with birth defects are 
diagnosed at younger ages than persons without birth defects. 
Bone marrow failure usually presents in childhood, with petechia, 
bruising, and hemorrhages due to thrombocytopenia; pallor and 
fatigue from anemia; and infections due to neutropenia. More 
than 90% of the children with FA develop pancytopenia caused 
by aplastic anemia, which is often fatal [1-3].
About 75% of children with FA have birth defects, such as 
altered skin pigmentation and/or café au lait spots (>50%), 
short stature (50%), thumb or thumb and radial anomalies 
(40%), abnormal male gonads (30%), microcephaly (25%), eye 
anomalies (20%), structural renal defects (20%), low birth weight 
(10%), developmental delay (10%), and abnormal ears or hearing 
(10%). Literature reports may, however, be biased toward this 
association because the clinical diagnosis was initially dependent 
on the combination of aplastic anemia and physical anomalies; 
thus, the frequencies may be overestimated [1,2,4].
The clinical phenotype is extremely variable; therefore, the 
diagnosis is frequently delayed until the pancytopenia appears. 
Thus, studies like ours on the clinical spectrum of presentation 
increase the awareness and improve the chances of early 
diagnosis of this rare disease. Timely diagnosis helps plan the 
appropriate treatment of FA-associated bone marrow failure and 
stem cell transplantation (SCT) protocols, which are different 
from treatment of acquired bone marrow failure.
ABSTRACT
Objectives: The aim of this study is to observe the clinical spectrum of presentation of Fanconi anemia (FA) in children presenting 
to the Hematology Department of Victoria Hospital, Bangalore Medical College and Research Institute. Materials and Methods: 
This observational study was carried out from February 2010 to December 2016 on all the 16 consecutive children <18 years of 
age, with FA. Those with high frequency of chromosomal breakage in G-banded metaphases from mitomycin-treated cultures were 
considered as positive cases. Results: The mean age at presentation was 6.79±1.34 years, but for those with dysmorphic features 
on examination, it was 4.77±0.98 years. Symptoms of anemia were seen in 14 (87.5%) and of bleeding in 8 (50%) cases. There 
was a history of prolonged fever at presentation in 5 (31.2%) cases. Dysmorphic features on examination were seen in 10 (62.5%) 
cases. Short stature and microcephaly and microphthalmia were the most common features. Pancytopenia was seen in 68.7% of the 
subjects at presentation and anemia in 87.5% of cases while thrombocytopenia was universal (100%). The mean hemoglobin was 
5.33±0.36 g/dL, mean white blood cell count was 3429.37±477.65/mm3, and mean platelet count was 28156.25±4199.44/mm3. The 
bone marrow was hypoplastic in 14 (87.5%). Pelvic kidney seen in 5 (31%) was the most common ultrasound finding. Parental 
consanguinity was seen in 50% of cases. Conclusion: Parental consanguinity was common, and there was a male preponderance 
in our study. The most common presenting manifestations were anemia followed by bleeding. Two-third of the patients had 
pancytopenia at diagnosis while thrombocytopenia was universal (100%). In the presence of a family history and/or dysmorphic 
features, even mono- or bi-cytopenias should be evaluated for inherited bone marrow failure syndromes.
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MATERIALS AND METHODS
This study included 16 consecutive children of FA who presented 
to the Hematology Department of Victoria Hospital, Bangalore 
Medical College and Research Institute, from February 2010 
to December 2016. Children <18 years of age with hypoplastic 
anemia, bone marrow failure, and/or dysmorphic features on 
examination were worked up to rule out FA. Those with high 
frequency of chromosomal breakage in G-banded metaphases 
from mitomycin-treated cultures were considered as positive 
cases.
Detailed clinical history including family history, mode of 
presentation, age of onset of the disease, associated symptoms, 
and drug history were noted. Pedigree analysis was done for 
each case, and a thorough clinical examination was performed 
on these children <18 years of age. Informed written consent 
was obtained for the use of patient information for research and 
studies.
The blood sample was subjected to routine hematological 
tests such as complete blood count using automated hematology 
analyzer (5 part Beckman LH 780 analyzer for HB, HCT, TLC, 
differential leukocyte count, and platelet count), and peripheral 
smear examination was performed. Routine liver and kidney 
function tests were done in all. Bone marrow aspirate and 
biopsy and routine karyotyping were performed in all children. 
Chromosome breakage was examined in short-term cultures 
of peripheral blood lymphocytes in the presence of MMC. 
Fetal hemoglobin (HbF) was estimated by semi-automated gel 
electrophoresis. Skeletal survey was performed to identify all 
developmental defects involving bone. An initial abdominal 
ultrasound was performed to look for size and location of the 
kidney and any other anomalies.
RESULTS
The mean age at presentation was 6.79±1.34 years (Range: 
2-18 years). The mean age at diagnosis of those with dysmorphic 
features on examination was 4.77±0.98 years. There were 
12 males and 4 females. The M:F ratio was 3:1. There was a 
history of parental consanguinity in 8 (50%) cases Table 1. 
Symptoms of anemia were seen in 14 (87.5%) and symptoms 
of bleeding such as skin and mucosal bleeds, hematemesis and 
hemoptysis in 8 (50%). One child presented with leukemia. There 
was a history of prolonged fever at presentation in 5 (31.2%). 
Developmental delay was seen in 3 (18.6%). Dysmorphic features 
on examination were seen in 10 (62.5%) of the children as shown 
in Table 2. Dysmorphic features on examination seen in our series 
included short stature, microphthalmia, microcephaly, hypoplastic 
thumb, polydactyly, and hyper- and hypo-pigmentation (Table 2). 
Short stature and microcephaly and microphthalmia were the 
most common, followed by hyperpigmentation, hypoplastic 
thumb, and polydactyly.
Pancytopenia was seen in 68.7% of the subjects at presentation 
and anemia in 87.5% while thrombocytopenia was universal (100%) 
(Fig. 1). The mean levels of hemoglobin was 5.33±0.36 g/dL, 
mean white blood cell count  was 3429.37±477.65/mm3, and 
mean platelet count  was 28156.25±4199.44/mm3. The bone 
marrow was hypoplastic in 14 (87.5%), hypercellular in 1 (6.2%), 
and showed features of acute myeloid leukemia in 1 (6.2%).
Routine karyotyping was normal in all 16 cases. Peripheral 
blood cytogenetics using G-banded metaphases from mitomycin-
treated cultures showed a high frequency of chromosomal 
breakage in all (100%) patients. HbF was elevated in all. Pelvic 
kidney, seen in 5 (31%) cases, was the most common ultrasound 
finding, followed by ectopic kidneys in 3(18.6%) and absent 
kidneys in 2 (12.4%). Absent uterus was seen in 1 female child 
(6.2%). On skeletal survey, absent radius was seen in 3 (18.6%) 
and absence of carpal bones was seen in 2 (12.4%) cases.
Table 2: Dysmorphic features seen on examination
Feature n (%)
Short stature 6 (60)
Microphthalmia 6 (60)
Microcephaly 6 (60)
Hypoplastic thumb 4 (40)
Polydactyly 4 (40)
Hyperpigmentation 4 (40)
Hypopigmentation 2 (20)
Café au lait spots 2 (20)
Anal agenesis 1 (10)
Undescended testes 2 (20)
Spinal dysraphism 2 (20)
Hearing defect 2 (20)
Figure 1: Hematological profile at presentation
Table 1: Clinical features at presentation
Clinical features n (%)
Anemia 14 (87.5)
Bleeding 8 (50)
Fever 5 (31.2)
Leukemia 1 (6.2)
Developmental delay 3 (18.6)
Dysmorphic features 10 (62.5)
Hepatomegaly 7 (43.7)
Splenomegaly 3 (18.6)
Hepatosplenomegaly 3 (18.6)
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DISCUSSION
Hypersensitivity of FA cells to the clastogenic effect of DEB 
or MMC provides a unique marker for the diagnosis before the 
beginning of hematological manifestations [3,5,6]. These agents 
lead to increased numbers of breaks, gaps, rearrangements, and 
quadriradii in FA homozygote cells. Bone marrow aspirate and 
biopsy may reveal hypocellularity, loss of myeloid and erythroid 
precursors and megakaryocytes (with relative lymphocytosis), or 
full-blown aplasia with a fatty marrow. HbF may be increased for 
age as a manifestation of stress erythropoiesis.
Treatment is recommended for significant cytopenias, such 
as Hb <8 g/dL, platelets <30,000/µL, or neutrophils <500/mm3. 
Although the first line of therapy is SCT, androgens usually 
oxymetholone 2-5 mg/kg/day, to which approximately 50-75% 
of children respond, are used for those in whom transplantation is 
not an option [1,2,4]. These improvements may be only in Hb, or 
bi- or tri-lineage, and may be brief or last for many years. Severe 
neutropenia may respond to granulocyte colony-stimulating 
factor, and some children also demonstrate an increase in Hb 
and platelets with this treatment [1,2,4]. While gene therapy is 
tantalizing in FA, it is not yet a reality [7,8]. If there is a human 
leukocyte antigen-matched sibling, SCT is the recommended 
course.
Supportive care for children with symptomatic anemia 
includes transfusions of packed red blood cells that have been 
leukodepleted. Symptomatic thrombocytopenia can be treated 
with similarly treated platelets; single-donor platelets are preferred 
to reduce the frequency of antibody formation. Hand surgery and 
splinting may be indicated for thumb and radial anomalies which 
should be performed early in life to ensure maximal function. 
Congenital heart defects may require surgery. GI anomalies, 
such as tracheoesophageal fistulas, are also treated surgically. 
The major cause of death in FA is bone marrow failure, followed 
in frequency by leukemia and solid tumors [7-9]. The projected 
median survival from all causes for more than 1000 cases reported 
in the literature is age of 20 years, although this has improved 
to older than 30 years in the cases reported in the most recent 
decade [8,10].
In our study, parental consanguinity was seen in 50% of cases, 
highlighting the importance of community education, premarital 
counseling, and promotion of eugenics. The mean age at 
presentation was 6.79±1.34 years, but for those with dysmorphic 
features on examination, it was 4.77±0.98 years. Thus, those 
with dysmorphic features on examination were diagnosed 
earlier as also reported by other researchers [9,11,12]. The 
clinico-hematological findings were similar to studies reported 
previously. There was a male preponderance in our study. The 
most common presenting manifestations were anemia followed 
by bleeding similar to studies from Azik et al. [13] and Auerbach 
et al. [14]. Two-third of the patients had pancytopenia at diagnosis 
while thrombocytopenia was universal (100%).
Developmental delay was seen in 3 (18.6%) and dysmorphic 
features on examination was seen in 10 (62.5%) of the children. 
Short stature and microcephaly and microphthalmia were 
the most common anomaly, followed by hyperpigmentation, 
hypoplastic thumb, and polydactyly similar to the findings of other 
studies [11-17]. Zen PR et al (PR stands for Paulo Ricardo) [16] 
and Auerbach et al. [14] have reported similar findings. Radial 
abnormalities, a classic finding of FA, are described in about 
50% of the children and mainly consist of absence or hypoplasia 
of the thumb, bifid or supernumerary thumbs, and absence or 
hypoplasia of the radius [9-11]. We found hypoplastic thumb in 
40%, polydactyly in 40%, and absent radius was seen in 18.6% 
and absence of carpal bones was seen in 12.4% cases in our study 
population.
Pelvic kidney, seen in 5 (31%) cases, was the most common 
ultrasound finding. Among the genital anomalies detected, 
2 (20%) males had undescended testes and 1 female had absent 
uterus. Around one-third of FA patients have been reported to 
have renal anomalies including unilateral renal aplasia, renal 
hypoplasia, horseshoe kidneys, or double ureters [11,12]. 
Males have a high incidence of genital abnormalities such 
as hypogenitalia, undescended testes, and hypospadias with 
infertility being the norm, although there have been reports of 
males with FA fathering children [11,12,18]. Females may also 
have underdeveloped genitalia and uterine anomalies; older 
females have sparse, irregular menses but can become pregnant if 
not on androgen therapy [11].
Although the study population was small, the numbers were 
reasonable for a single center and a rare disease. Larger and 
multicenter studies would be useful to throw more light on the 
clinical spectrum of FA in children.
CONCLUSION
Parental consanguinity was common in our study highlighting 
the importance of community and youth education, pre-marital 
counseling, and promotion of eugenics. There was a male 
preponderance in our study. The most common presenting 
manifestations were anemia followed by bleeding. Two-third of 
the patients had pancytopenia at diagnosis while thrombocytopenia 
was universal (100%). In the presence of a family history and/
or dysmorphic features, even mono- or bi-cytopenias should be 
evaluated for inherited bone marrow failure syndromes. Larger 
and multicenter studies would be useful to throw more light on 
the clinical spectrum of FA in children.
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